U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901712) titled 'Blood NfL and Functional Outcomes After Moderate-to-Severe TBI' on Oct. 22.

Brief Summary: Prospective cohort study of 150 adults with moderate-to-severe TBI. Blood NfL is measured at admission, day 1, and day 3 to examine its relationship, alone and with CT imaging, to 3-month functional outcome (GOSE).

Study Start Date: May 01, 2027

Study Type: OBSERVATIONAL

Condition: Traumatic Brain Injury

Intervention: DIAGNOSTIC_TEST: neurofilament light chain ECLIA

University Hospital phlebotomists will collect blood during scheduled clinical blood collection at admission, day 1, and day 3, including one additional 1 mL research tube d...